Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05114616 · ClinicalTrials.gov registry record · NA
Assessment of Consciousness States with NextSense Ear Bud Devices
A NA study, sponsored by Emory University.
- Completed
- Registry status
- NA
- Development phase
- 16
- Enrollment target
NCT05114616 is a NA study that has completed, run by Emory University. The registered enrollment target is 16 participants.
The verdict
NCT05114616, a NA study, has completed, sponsored by Emory University.
- COMPLETED
- Registry status
- NA
- Development phase
- 16 participants
- Enrollment target
Study Summary
The goal of this study is to determine the feasibility in continuing to explore NextSense's ear-EEG device (EEGBud) and Ellcie Healthy glasses as wireless, wearable alternatives to the expense, discomfort, and burden in conventional surface electrodes and hardwired signal amplification for assessing consciousness states such as wake from sleep.
Interventions
- DEVICE NextSense EEG-enabled earbuds
- DEVICE Ellcie Healthy Glasses
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2021-11-18 |
| Est. Completion | 2023-09-22 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05114616
The ClinicalTrials.gov registry entry for NCT05114616 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which NextSense EEG-enabled earbuds is the first listed.
NCT05114616 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05114616 about?
NCT05114616 is a clinical study titled "Assessment of Consciousness States with NextSense Ear Bud Devices". The goal of this study is to determine the feasibility in continuing to explore NextSense's ear-EEG device (EEGBud) and Ellcie Healthy glasses as wireless, wearable alternatives to the expense, discomfort, and burden in conventional surface electrodes and hardwired signal amplification for assessing...
What is the current status of trial NCT05114616?
This trial is currently completed. It is a NA study. The enrollment target is 16 participants. The study started on 2021-11-18. Estimated completion is 2023-09-22.
What interventions are being tested in trial NCT05114616?
The interventions under investigation include: NextSense EEG-enabled earbuds (DEVICE), Ellcie Healthy Glasses (DEVICE).
Who is sponsoring clinical trial NCT05114616?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.